UK's first rooftop intensive care ward opens at King's College Hospital to aid patient recovery
By
Vicki Loader
Crispy enough to crunch, soft enough to enjoy. A good bake.
Summary
King's College Hospital in London has opened the UK's first rooftop intensive care ward, designed to aid patient recovery through exposure to fresh air, sunlight, and the outdoors. The first patient, Hollie Allan (29), who had been in intensive care for two months, was moved to the outdoor ward and had an emotional response to being outside again. The initiative aims to study how outdoor exposure boosts recovery for seriously ill patients.
Key quotes
· 3 pulledBrace yourself for the cold!
I'm sorry, it's so nice. It's so beautiful.
I forgot what it feels like to be outside.
You might also wanna read

WHO chief urges community cooperation to contain Ebola outbreak in eastern DRC
The World Health Organization's director general, Tedros Adhanom Ghebreyesus, appealed for community cooperation in containing the Ebola out
Cambridge hospital meets NHS waiting list target ahead of 2026 deadline
New NHS data shows waiting lists at Cambridge hospital are improving, with the national target of having at least 65% of patients waiting no
Brazil monitors two patients for possible Ebola as DR Congo outbreak surpasses 1,000 cases
Brazil is monitoring two patients for possible Ebola infection amid the ongoing outbreak in DR Congo, which has over 1,000 suspected cases a
Duke Health settles $3.7M class-action lawsuit over patient data shared with Meta
Duke University Health System has reached a $3.7 million class-action settlement after patients alleged their personal data was shared with
SCP study: 5.5 million Dutch provide informal care, with growing burden on men and over-55s
The article reports on a new SCP study revealing that 5.5 million Dutch people now provide informal care (mantelzorg), with men and those ov
Health officials urge weight loss jab users to call 111 if they experience serious side effects
The article warns Brits using weight loss jabs (GLP-1 inhibitors) about a potentially dangerous side effect affecting around 1 in 100 patien
